ArticleFrontiers in medicine2021
COVID-19 Vaccination: Concerns About Its Accessibility, Affordability, and Acceptability.
Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- The impacts of COVID-19 on routine immunization for children in Rwanda.BMC infectious diseases · 2026Article
- Exploring vaccine hesitancy and acceptance in the general population of Pakistan: Insights into COVID-19-related distress, risk perception, and stigma.Human vaccines & immunotherapeutics · 2024Article
- COVID-19 vaccine hesitancy among medical students, health professionals, and health care workers: an umbrella review.Clinical and experimental vaccine research · 2024Review
- Building confidence in the COVID-19 vaccine in a polio-endemic country: strategic communication lessons from Pakistan.BMJ global health · 2024Article
- The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region.Advances in experimental medicine and biology · 2024Review
- COVID-19 booster dose vaccination of healthcare workers in Qatar: A web-based cross-sectional survey.Public health challenges · 2023Article
- Factors Influencing Monkeypox Vaccination: A Cue to Policy Implementation.Journal of epidemiology and global health · 2023Article
- Implications of COVID-19 and "super floods" for routine vaccination in Pakistan: The reemergence of vaccine preventable-diseases such as polio and measles.Human vaccines & immunotherapeutics · 2022Article
- Review
- Willingness to receive COVID-19 vaccination in people living with HIV/AIDS from Latin America.International journal of STD & AIDS · 2022Article
- Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach.International journal of biological macromolecules · 2022Article
- Review
- Evaluating spatial accessibility to COVID-19 vaccine resources in diversely populated counties in the United States.Frontiers in public health · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By the mid of June 2021, after an almost 1.5-year-long COVID-19 pandemic that has significantly affected the world in multiple ways, various vaccines against COVID-19 have arrived and started worldwide. Yet, economic, (geo)political, and socio-cultural factors may influence its uptake at individual and country levels. Several issues will (and already have been reported in media) revolve around this vaccination regarding its accessibility, affordability, and acceptability at an individual level and a country level. Given that in this commentary, we provoke a discussion: Who-a country as well as the individuals-would have access to it, and who would economically afford it, and who would accept it? Centering these intriguing questions, we revisit the body of literature that explicates vaccine hesitancy, refusal, and resistance, and we also draw on the current literature and media reports about vaccination against COVID-19. We suggest that these backdrops need essential attention so that everyone can afford, accept, and have access to it. Otherwise, the current risk in the face of a year-old pandemic will continue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.